145 related articles for article (PubMed ID: 11274596)
21. Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells.
Stroncek DF; Clay ME; Petzoldt ML; Smith J; Jaszcz W; Oldham FB; McCullough J
Transfusion; 1996 Jul; 36(7):601-10. PubMed ID: 8701455
[TBL] [Abstract][Full Text] [Related]
22. A comparative study of adverse reactions occurring after administration of glycosylated granulocyte colony stimulating factor and/or dexamethasone for mobilization of neutrophils in healthy donors.
Heuft HG; Goudeva L; Blasczyk R
Ann Hematol; 2004 May; 83(5):279-85. PubMed ID: 15060747
[TBL] [Abstract][Full Text] [Related]
23. Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony-stimulating factor.
Falanga A; Marchetti M; Evangelista V; Manarini S; Oldani E; Giovanelli S; Galbusera M; Cerletti C; Barbui T
Blood; 1999 Apr; 93(8):2506-14. PubMed ID: 10194429
[TBL] [Abstract][Full Text] [Related]
24. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience.
Anderlini P; Donato M; Chan KW; Huh YO; Gee AP; Lauppe MJ; Champlin RE; Körbling M
Transfusion; 1999 Jun; 39(6):555-60. PubMed ID: 10378833
[TBL] [Abstract][Full Text] [Related]
25. Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia.
Locatelli F; Pession A; Zecca M; Bonetti F; Prete L; Carrà AM; Prete A; Montagna D; Comoli P; Taibi RM; Paolucci G
Bone Marrow Transplant; 1996 Jan; 17(1):31-7. PubMed ID: 8673051
[TBL] [Abstract][Full Text] [Related]
26. Modification of the content of plasma protein carbonyl groups in donors after granulocyte colony stimulating factor-induced stem cell mobilization.
Morabito F; Tomaino A; Cristani M; Cimino F; Martino M; Minciullo PL; Calabrò C; Saija A; Gangemi S
Transfus Apher Sci; 2005 Oct; 33(2):141-6. PubMed ID: 16103013
[TBL] [Abstract][Full Text] [Related]
27. Effective storage of granulocytes collected by centrifugation leukapheresis from donors stimulated with granulocyte-colony-stimulating factor.
Hubel K; Rodger E; Gaviria JM; Price TH; Dale DC; Liles WC
Transfusion; 2005 Dec; 45(12):1876-89. PubMed ID: 16371040
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic-blood stem-cell collection following mobilization with low-dose granulocyte colony-stimulating factor.
Bishop MR; Tarantolo SR; Jackson JD; Anderson JR; Schmit-Pokorny K; Zacharias D; Pavletic ZS; Pirruccello SJ; Vose JM; Bierman PJ; Warkentin PI; Armitage JO; Kessinger A
J Clin Oncol; 1997 Apr; 15(4):1601-7. PubMed ID: 9193359
[TBL] [Abstract][Full Text] [Related]
29. Sequential changes in stem cell markers in peripheral blood and leukapheresis samples after injections of recombinant human granulocyte colony-stimulating factor in patients with urogenital malignant solid tumors: a preliminary study.
Samma S; Momose H; Ozono S; Hirao Y; Okajima E; Morii T; Nishikawa K; Shimoyama T; Fujimura Y
Jpn J Clin Oncol; 1994 Oct; 24(5):269-74. PubMed ID: 7526017
[TBL] [Abstract][Full Text] [Related]
30. Blood oxidative status and selectins plasma levels in healthy donors receiving granulocyte-colony stimulating factor.
Cella G; Marchetti M; Vignoli A; Randi ML; Saggiorato G; Pasetto L; Pagnan A; Barbui T; Falanga A
Leukemia; 2006 Aug; 20(8):1430-4. PubMed ID: 16775616
[TBL] [Abstract][Full Text] [Related]
31. High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection.
Engelhardt M; Bertz H; Afting M; Waller CF; Finke J
J Clin Oncol; 1999 Jul; 17(7):2160-72. PubMed ID: 10561272
[TBL] [Abstract][Full Text] [Related]
32. Autologous transplantation of blood stem cells mobilized with filgrastim alone in 93 patients with malignancies: the number of CD34+ cells reinfused is the only factor predicting both granulocyte and platelet recovery.
Faucher C; Le Corroller AG; Chabannon C; Viens P; Stoppa AM; Bouabdallah R; Camerlo J; Vey N; Gravis G; Gastaut JA; Novakovitch G; Mannoni P; Bardou VJ; Moatti JP; Maraninchi D; Blaise D
J Hematother; 1996 Dec; 5(6):663-70. PubMed ID: 9117255
[TBL] [Abstract][Full Text] [Related]
33. [Clinical study of single-dose G-CSF in mobilization and reconstruction of allogeneic peripheral blood stem cell transplantation].
Tian H; Zhou SY
Ai Zheng; 2003 Dec; 22(12):1325-9. PubMed ID: 14693061
[TBL] [Abstract][Full Text] [Related]
34. Transfusions of granulocyte-colony-stimulating factor-mobilized granulocyte components to allogeneic transplant recipients: analysis of kinetics and factors determining posttransfusion neutrophil and platelet counts.
Adkins D; Spitzer G; Johnston M; Velasquez W; Dunphy F; Petruska P
Transfusion; 1997 Jul; 37(7):737-48. PubMed ID: 9225939
[TBL] [Abstract][Full Text] [Related]
35. Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone.
Alegre A; Tomás JF; Martínez-Chamorro C; Gil-Fernández JJ; Fernández-Villalta MJ; Arranz R; Díaz MA; Granda A; Bernardo MR; Escudero A; López-Lorenzo JL; Fernández-Rañada JM
Bone Marrow Transplant; 1997 Aug; 20(3):211-7. PubMed ID: 9257889
[TBL] [Abstract][Full Text] [Related]
36. Eighteen years experience of granulocyte donations-acceptable donor safety?
Axdorph Nygell U; Sollén-Nilsson A; Lundahl J
J Clin Apher; 2015 Oct; 30(5):265-72. PubMed ID: 25546372
[TBL] [Abstract][Full Text] [Related]
37. Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis.
Körbling M; Reuben JM; Gao H; Lee BN; Harris DM; Cogdell D; Giralt SA; Khouri IF; Saliba RM; Champlin RE; Zhang W; Estrov Z
Transfusion; 2006 Oct; 46(10):1795-802. PubMed ID: 17002637
[TBL] [Abstract][Full Text] [Related]
38. Collection of two consecutive neutrophil concentrates for transfusion from donors mobilized with glycosylated granulocyte-CSF plus dexamethasone.
Heuft HG; Goudeva L; Schwella N; Blasczyk R
Transfusion; 2004 May; 44(5):750-7. PubMed ID: 15104658
[TBL] [Abstract][Full Text] [Related]
39. Impact of preleukapheresis cell counts on collection results and correlation of progenitor-cell dose with engraftment after high-dose chemotherapy in patients with germ cell cancer.
Schwella N; Beyer J; Schwaner I; Heuft HG; Rick O; Huhn D; Serke S; Siegert W
J Clin Oncol; 1996 Apr; 14(4):1114-21. PubMed ID: 8648365
[TBL] [Abstract][Full Text] [Related]
40. Tolerance of granulocyte donors towards granulocyte colony-stimulating factor stimulation and of patients towards granulocyte transfusions: results of a multicentre study.
Bux J; Cassens U; Dielschneider T; Duchscherer M; Edel E; Eichler H; Haas C; Moog R; Peschke H; Peters C; Ryzenkov I; Schlenke P; Ullrich H; Wiesneth M
Vox Sang; 2003 Nov; 85(4):322-5. PubMed ID: 14633259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
